Enterprise Diagnostics, Inc.
Regulation Crowdfunding offering on Wefunder · Form C filed February 23, 2026 · Carrollton, Texas
Enterprise Diagnostics, Inc., a Delaware corporation converted from a Texas LLC on January 7, 2026, plans to sell an AI-powered operational intelligence platform built on Palantir Foundry to private equity firms and their portfolio companies, starting with a $100,000 60-day paid diagnostic. The company is pre-revenue, reports $0 revenue and a net loss of $9,486.36 from inception (September 17, 2025) to December 31, 2025, and is offering SAFEs with a $50,000 target and $124,000 maximum.
Profile details below were extracted automatically from the issuer's filing documents. Figures in the financial table come directly from the SEC's structured Form C data.
Offering terms
- Security
- Simple Agreement for Future Equity (SAFE)
- Maximum
- $124,000.00
- Price
- $1.00 per unit
- Pricing method
- Pro-rated portion of the total principal value of $50,000; interests will be sold in increments of $1; each investment is convertible to one share of stock as described under Item 13.
- Deadline
- April 30, 2027
- Oversubscriptions
- Accepted
- Intermediary
- Wefunder Portal LLC
Funding portal, SEC file 007-00033 - Intermediary fee
- <p>6.9% of the offering amount upon a successful fundraise, and be entitled to reimbursement for out-of-pocket third party expenses it pays or incurs on behalf of the Issuer in connection with the offering.</p>
- Intermediary equity
- No
- Co-issuer
- Enterprise Diagnostics I, a series of Wefunder SPV, LLC
Enterprise Diagnostics I EB, a series of Wefunder SPV, LLC
Financials as filed
| Item | Most recent FY | Prior FY |
|---|---|---|
| Revenue | $0 | $0 |
| Cost of goods sold | $0 | $0 |
| Net income (loss) | -$9,486 | $0 |
| Total assets | $0 | $0 |
| Cash and equivalents | $0 | $0 |
| Accounts receivable | $0 | $0 |
| Short-term debt | $9,486 | $0 |
| Long-term debt | $0 | $0 |
| Taxes paid | $0 | $0 |
Two fiscal years as reported on the Form C cover sheet. 1 employees. Offered in 56 states.
Use of proceeds
At the $50,000 target: 32.1% delivery team, 36% product, 15% sales and marketing, 10% operations, and 6.9% Wefunder fee. At the $124,000 maximum: the same percentages applied to the larger amount, with the company stating it would accelerate product development and expand sales, marketing and operations.
Valuation
Form C Item 13 states a valuation cap of $12,000,000 with a 60% discount rate, and a $10,800,000 valuation cap with an 80% discount rate for the first $100,000 invested. The Terms Appendix in one set of exhibits shows a $10.8M cap and 20% discount, and another shows a $12M cap and 20% discount. The SAFE forms show a 80% discount rate with either $10,800,000 or $12,000,000 pre-money valuation cap. Cover page price is $1.00000 per interest, with interests sold in $1 increments as a pro-rated portion of the $50,000 target. Item 21 states the offering price was set arbitrarily by the company without an outside appraisal.
Prior raises
Not stated
Financial statements
Financial statements for the period from September 17, 2025 (inception) to December 31, 2025 are labeled unaudited. No auditor or reviewing CPA is named, and the risk factors state the company has not provided audited financial statements.